Growth Metrics

Biocryst Pharmaceuticals (BCRX) Other Working Capital Changes: 2010-2015

Historic Other Working Capital Changes for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to -$403,000.

  • Biocryst Pharmaceuticals' Other Working Capital Changes fell 107.59% to -$403,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $1.2 million, marking a year-over-year decrease of 72.93%. This contributed to the annual value of -$2.0 million for FY2024, which is 128.72% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Other Working Capital Changes of -$403,000 as of Q4 2015, which was up 90.45% from -$4.2 million recorded in Q3 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Other Working Capital Changes registered a high of $7.7 million during Q2 2015, and its lowest value of -$7.7 million during Q1 2012.
  • For the 3-year period, Biocryst Pharmaceuticals' Other Working Capital Changes averaged around $377,083, with its median value being -$329,500 (2013).
  • Data for Biocryst Pharmaceuticals' Other Working Capital Changes shows a peak YoY increase of 2,381.55% (in 2015) and a maximum YoY decrease of 1,320.20% (in 2015) over the last 5 years.
  • Biocryst Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$553,000 in 2011, then soared by 61.84% to -$211,000 in 2012, then slumped by 71.56% to -$362,000 in 2013, then surged by 1,566.57% to $5.3 million in 2014, then plummeted by 107.59% to -$403,000 in 2015.
  • Its last three reported values are -$403,000 in Q4 2015, -$4.2 million for Q3 2015, and $7.7 million during Q2 2015.